2012
DOI: 10.1111/j.1600-6143.2012.04288.x
|View full text |Cite
|
Sign up to set email alerts
|

Liver Defatting: An Alternative Approach to Enable Steatotic Liver Transplantation

Abstract: Macrovesicular steatosis in greater than 30% of hepatocytes is a significant risk factor for primary graft nonfunction due to increased sensitivity to ischemia reperfusion (I/R) injury. The growing prevalence of hepatic steatosis due to the obesity epidemic, in conjunction with an aging population, may negatively impact the availability of suitable deceased liver donors. Some have suggested that metabolic interventions could decrease the fat content of liver grafts prior to transplantation. This concept has be… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
76
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(78 citation statements)
references
References 41 publications
1
76
0
Order By: Relevance
“…Strategies to improve such non-optimal organs imply donor pretreatments and ex vivo perfusion techniques to rescue Advanced Drug Delivery Reviews 88 (2015) [67][68][69][70][71][72][73][74][75][76][77] ☆ This review is part of the Advanced Drug Delivery Reviews theme issue on "MicroRNAs in tissue engineering and regenerative medicine". the diseased organs [3,[5][6][7]. On the other hand, tissue-engineered solutions have been developed and are under development to temporarily or definitively support or replace the diseased liver.…”
Section: Introductionmentioning
confidence: 99%
“…Strategies to improve such non-optimal organs imply donor pretreatments and ex vivo perfusion techniques to rescue Advanced Drug Delivery Reviews 88 (2015) [67][68][69][70][71][72][73][74][75][76][77] ☆ This review is part of the Advanced Drug Delivery Reviews theme issue on "MicroRNAs in tissue engineering and regenerative medicine". the diseased organs [3,[5][6][7]. On the other hand, tissue-engineered solutions have been developed and are under development to temporarily or definitively support or replace the diseased liver.…”
Section: Introductionmentioning
confidence: 99%
“…Because the obese population has been increasing, the number of individuals with hepatic steatosis has been growing accordingly, which may impact the availability of suitable liver donors (Nativ et al, 2012). Steatotic liver grafts are more susceptible to ischemia-reperfusion (I/R) injury, with increased lipid peroxidation (Vairetti et al, 2009;Ben Mosbah et al, 2010), increased release of proinflammatory mediators (Selzner and Clavien, 2001;Vairetti et al, 2009), and increased neutrophil infiltration (Nakano et al, 1997).…”
Section: Introductionmentioning
confidence: 99%
“…This would be greatly facilitated if a suitable cell culture model of hepatic steatosis were available to perform both screening and mechanistic studies in an efficient manner, prior to testing in actual livers. 106 While many challenges need to be overcome, liver defatting is a potentially promising approach to reduce the sensitivity of steatotic livers to I/R injury, and a new modality that may enable the successful recovery of a large number of livers that would otherwise be discarded.…”
mentioning
confidence: 99%
“…Liver defatting: Multiple studies described what is called "liver defatting", which have been performed in attempts to optimize the steatotic liver grafts prior to LT. 106,110 Combined measures (Dietary, exercise and drug therapy): A short-term intensive treatment with protein-rich diet (1000kcal/day), exercise (600 kcal/day), and bezafibrate (400mg/day) for 2-8weeks in a small trial of 11donors led to threefold decrease in MaS and reduced body weight and BMI. Alternatively, the consumption of omega-3 FAs for 1month was used to decrease MaS in three candidates for LDLT who had biopsy-proven hepatic MaS >30% prior to donation.…”
mentioning
confidence: 99%
See 1 more Smart Citation